Filing Details

Accession Number:
0001161697-19-000538
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-12-06 16:52:22
Reporting Period:
2019-12-04
Accepted Time:
2019-12-06 16:52:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1369568 Catalyst Pharmaceuticals Inc. CPRX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1279473 Gary Ingenito 355 Alhambra Circle, Suite 1250
Coral Gables FL 33134
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Per Share Acquisiton 2019-12-04 150,000 $2.53 150,000 No 4 M Direct
Common Stock, Par Value $0.001 Per Share Disposition 2019-12-05 150,000 $4.82 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Options to purchase common stock Acquisiton 2019-12-04 150,000 $0.00 150,000 $2.53
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
886,000 2022-12-30 No 4 M Direct
Footnotes
  1. Dr. Ingenito has advised the Company that this sale of shares was to complete the raising of funds required for the purchase of a home by a family member and does not relate to any disagreements with the Company on any matter relating to the Company's operations, policies and practices. Dr. Ingenito remains an officer of the Company.
  2. The option was granted on December 30, 2015 and previously vested in two equal annual installments.